About the Ewings Sarcoma Session
Ewing's sarcoma, a rare form of bone cancer, primarily affects children and young adults. Despite advances in cancer research, treatment challenges persist due to its aggressive nature and tendency to metastasize. Current research focuses on targeted therapies aimed at disrupting the genetic mutations driving tumor growth, such as the fusion of EWSR1 gene with ETS transcription factors. Immunotherapy, utilizing the body's immune system to attack cancer cells, holds promise in enhancing treatment outcomes. Additionally, advancements in precision medicine allow for tailored therapies based on individual tumor characteristics, improving efficacy and minimizing side effects. Collaborative efforts between researchers, clinicians, and pharmaceutical companies are essential to continue unraveling the complexities of Ewing's sarcoma and develop more effective treatment strategies.
Topics Covered in Ewings Sarcoma
FET-ETS Fusions
Small Round Cell Tumors
Extraskeletal Disease
Dose-Dense Chemotherapy
Local Control Options
Relapsed Disease
Related Scientific Sessions at CIOC 2027
Why Attend the Ewings Sarcoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Ewings Sarcoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Ewings Sarcoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Ewings Sarcoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ewings Sarcoma Conference 2027 — FAQs
What is the Ewings Sarcoma track at CIOC 2027?
The Ewings Sarcoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ewings Sarcoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ewings Sarcoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Ewings Sarcoma are all welcome — whether presenting or attending.
Can I present my research in the Ewings Sarcoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ewings Sarcoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Ewings Sarcoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.